CP
ZBH icon

Camelot Portfolios’s Zimmer Biomet ZBH Stock Holding History

Camelot Portfolios’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$945K Sell
10,971
-1,224
-10% -$107K 0.66% 47
2026
Q1 		$1.1M Sell
12,195
-970
-7% -$89K 0.82% 38
2025
Q4 		$1.18M Buy
13,165
+1,562
+13% +$148K 0.73% 40
2025
Q3 		$1.14M Buy
11,603
+209
+2% +$20.7K 0.67% 49
2025
Q2 		$1.04M Sell
11,394
-196
-2% -$19K 0.62% 49
2025
Q1 		$1.31M Buy
11,590
+7,156
+161% +$766K 0.81% 36
2024
Q4 		$468K Buy
4,434
+601
+16% +$64.5K 0.51% 70
2024
Q3 		$414K Sell
3,833
-5,914
-61% -$645K 0.41% 78
2024
Q2 		$1.06M Buy
9,747
+5,990
+159% +$706K 0.6% 51
2024
Q1 		$496K Sell
3,757
-4,791
-56% -$598K 0.48% 72
2023
Q4 		$1.04M Buy
8,548
+5,361
+168% +$598K 0.62% 45
2023
Q3 		$358K Sell
3,187
-2,646
-45% -$336K 0.34% 86
2023
Q2 		$849K Buy
5,833
+753
+15% +$102K 0.53% 60
2023
Q1 		$656K Sell
5,080
-373
-7% -$46.8K 0.46% 69
2022
Q4 		$695K Buy
+5,453
New +$633K 0.51% 61

Other funds holding ZBH

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
QAM
QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NCM
Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Camelot Portfolios's ZBH Position: Q2 2026 in Review

Camelot Portfolios reduced its Zimmer Biomet (ZBH) stake by 10% in Q2 2026, selling an estimated $107K and leaving 10,971 shares worth $945K. The position accounts for 0.66% of the portfolio, ranked #47.

Camelot Portfolios first reported a position in ZBH in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.31M in Q1 2025. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Camelot Portfolios held 10,971 shares of Zimmer Biomet worth $945K as of Q2 2026.
  • Camelot Portfolios sold 1,224 Zimmer Biomet shares in Q2 2026, an estimated $107K.
  • Zimmer Biomet made up 0.66% of Camelot Portfolios's portfolio in Q2 2026, its #47 holding.
  • Camelot Portfolios first reported a position in Zimmer Biomet in Q4 2022 and has held it in 15 quarters since.
  • Camelot Portfolios's Zimmer Biomet position peaked at $1.31M in Q1 2025.
  • 132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Camelot Portfolios's 13F filing for Q2 2026, filed 17 Jul 2026.